Neko Health

Investor: Undisclosed Investors

HealthTech pioneer Neko Health has completed a $700 million Series C funding round to support its international expansion into the United States. Summary of transaction details: Value: $700 million Sector: Healthcare & Biotech Advisor: Not disclosed Key Entities: Neko Health, Daniel Ek, Hjalmar Nilsonne Location: New York, USA Note: The capital injection enables Neko Health to bring its innovative non-invasive health scanning technology to the US market, targeting high rates of chronic disease through early detection and preventive care.

Investor: Lightspeed Venture Partners

Neko Health, a HealthTech company co-founded by Spotify's Daniel Ek, has successfully secured $700 million in a Series C funding round. This investment, led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, will support the expansion of its innovative 60-minute comprehensive health assessment scans.Summary of transaction details:Value: $700 millionSector: Healthcare & Biotech (HealthTech)Advisor: Not mentionedKey Entities: Target: Neko Health; Lead Investors: Lightspeed Venture Partners, O.G. Venture PartnersLocation: N/ANote: This significant Series C funding round underscores strong investor confidence in Neko Health's pioneering approach to preventative healthcare. The capital injection will enable the company to further develop its proprietary scanning technology and expand its clinic footprint, making advanced health assessments more widely accessible.